Home The Word Brain My Amedeo FAQ Privacy About   


C49

In our changing world, speaking just English isn't enough. Open new doors with skills in another world language.

Start with 7 words a day.

Next week: +49.


  Influenza

  Free Subscription


Articles published in J Immunol

Retrieve available abstracts of 53 articles:
HTML format



Single Articles


    May 2025
  1. NOURI HR, Schaunaman N, Kraft M, Numata M, et al
    Tollip deficiency enhances mitophagy and reduces STING activation in influenza A virus-infected mice.
    J Immunol. 2025 May 16:vkaf058. doi: 10.1093.
    PubMed     Abstract available


    April 2025
  2. MADRID DMC, Gu W, Karim SJI, Lowke MT, et al
    Single-cell analysis of pig lung leukocytes and their response to influenza infection and oseltamivir therapy.
    J Immunol. 2025 Apr 15:vkaf032. doi: 10.1093.
    PubMed     Abstract available


  3. HATIPOGLU I, Ainsua-Enrich E, Kadel S, Turner S, et al
    IRF4-regulated transcriptional and functional heterogeneity of lung-resident CD11b+ cDC2 subsets during influenza virus infection.
    J Immunol. 2025 Apr 10:vkaf060. doi: 10.1093.
    PubMed     Abstract available


  4. DINANT S, Castille J, Deloizy C, Bruder E, et al
    The prion-family protein Doppel exerts a protective role during influenza virus infection.
    J Immunol. 2025 Apr 9:vkaf031. doi: 10.1093.
    PubMed     Abstract available


    March 2025
  5. RAO AS, Ugwu N, Onufer AP, Kumova O, et al
    Cathelicidin-related antimicrobial peptide (CRAMP) is toxic during neonatal murine influenza virus infection.
    J Immunol. 2025 Mar 18:vkae053. doi: 10.1093.
    PubMed     Abstract available


    February 2025
  6. WANG M, Liu C, Fan Q, Sun Y, et al
    Rapid clonal expansion and somatic hypermutation contribute to the fate of SARS-CoV-2 broadly neutralizing antibodies.
    J Immunol. 2025;214:278-289.
    PubMed     Abstract available


    January 2025
  7. GROVENSTEIN P, Bhatnagar N, Kim KH, Pal SS, et al
    Influenza 5xM2e mRNA lipid nanoparticle vaccine confers broad immunity and significantly enhances the efficacy of inactivated split vaccination when coadministered.
    J Immunol. 2025;214:104-114.
    PubMed     Abstract available


  8. QIAO P, Yue C, Peng W, Liu K, et al
    Precise motif and cross-presentation of coronavirus peptides by feline MHC class I: implications for the mild infection of SARS-CoV-2.
    J Immunol. 2025;214:115-129.
    PubMed     Abstract available


    November 2024
  9. TONG X, Deng Y, Cizmeci D, Fontana L, et al
    Distinct Functional Humoral Immune Responses Are Induced after Live Attenuated and Inactivated Seasonal Influenza Vaccination.
    J Immunol. 2024 Nov 17:ji2200956. doi: 10.4049/jimmunol.2200956.
    PubMed     Abstract available


  10. DICK JK, Sangala JA, Krishna VD, Khaimraj A, et al
    NK Cell and Monocyte Dysfunction in Multisystem Inflammatory Syndrome in Children.
    J Immunol. 2024;213:1452-1466.
    PubMed     Abstract available


    October 2024
  11. RAJU N, Kramer KJ, Cavallaro M, Diotti RA, et al
    Multiplexed Antibody Sequencing and Profiling of the Human Hemagglutinin-specific Memory B Cell Response following Influenza Vaccination.
    J Immunol. 2024 Oct 23:ji2400326. doi: 10.4049/jimmunol.2400326.
    PubMed     Abstract available


    September 2024
  12. DRUSKOVIC M, Lucovnik M, Mesaric VA, Kavsek G, et al
    Immune Response to SARS-CoV-2 in Vaccine-naive Pregnant Women: Assessment of IgG and IgA Antibody Profile at Delivery and 42 Days Postpartum.
    J Immunol. 2024 Sep 11:ji2400055. doi: 10.4049/jimmunol.2400055.
    PubMed     Abstract available


  13. HOLDER KA, Ings DP, Fifield KE, Barnes DA, et al
    Sequence Matters: Primary COVID-19 Vaccination after Infection Elicits Similar Anti-spike Antibody Levels, but Stronger Antibody Dependent Cell-mediated Cytotoxicity than Breakthrough Infection.
    J Immunol. 2024 Sep 9:ji2400250. doi: 10.4049/jimmunol.2400250.
    PubMed     Abstract available


  14. IZADI A, Godzwon M, Soderlund Strand A, Schmidt T, et al
    Protective Non-neutralizing anti-N-terminal Domain mAb Maintains Fc-mediated Function against SARS-COV-2 Variants up to BA.2.86-JN.1 with Superfluous In Vivo Protection against JN.1 Due to Attenuated Virulence.
    J Immunol. 2024;213:678-689.
    PubMed     Abstract available


    June 2024
  15. HE Z, Li W, Zhang M, Huang M, et al
    RNF216 Inhibits the Replication of H5N1 Avian Influenza Virus and Regulates the RIG-I Signaling Pathway in Ducks.
    J Immunol. 2024 Jun 3:ji2300540. doi: 10.4049/jimmunol.2300540.
    PubMed     Abstract available


  16. LEIGHTON PA, Ching K, Reynolds K, Vuong CN, et al
    Chickens with a Truncated Light Chain Transgene Express Single-Domain H Chain-Only Antibodies.
    J Immunol. 2024;212:1744-1753.
    PubMed     Abstract available


  17. LEE MJ, de Los Rios Kobara I, Barnard TR, Vales Torres X, et al
    NK Cell-Monocyte Cross-talk Underlies NK Cell Activation in Severe COVID-19.
    J Immunol. 2024;212:1693-1705.
    PubMed     Abstract available


    May 2024
  18. BOUCHER J, Gilbert C, Bose S, Tessier PA, et al
    S100A9: The Unusual Suspect Connecting Viral Infection and Inflammation.
    J Immunol. 2024;212:1523-1529.
    PubMed     Abstract available


  19. SAITO S, Bozorgmehr N, Sligl W, Osman M, et al
    The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2-Infected Individuals with Severe Disease.
    J Immunol. 2024;212:1540-1552.
    PubMed     Abstract available


    April 2024
  20. BUDYLOWSKI P, Chau SLL, Banerjee A, Guvenc F, et al
    A Significant Contribution of the Classical Pathway of Complement in SARS-CoV-2 Neutralization of Convalescent and Vaccinee Sera.
    J Immunol. 2024 Apr 29:ji2300320. doi: 10.4049/jimmunol.2300320.
    PubMed     Abstract available


  21. KUNDURA L, Cezar R, Ballongue E, Andre S, et al
    Low Percentage of Perforin-Expressing NK Cells during Severe SARS-CoV-2 Infection: Consumption Rather than Primary Deficiency.
    J Immunol. 2024;212:1105-1112.
    PubMed     Abstract available


  22. ABE K, Beer JC, Nguyen T, Ariyapala IS, et al
    Cross-Platform Comparison of Highly Sensitive Immunoassays for Inflammatory Markers in a COVID-19 Cohort.
    J Immunol. 2024;212:1244-1253.
    PubMed     Abstract available


    March 2024
  23. LI W, Lin Y, Wang X, Yang H, et al
    Chicken UFL1 Restricts Avian Influenza Virus Replication by Disrupting the Viral Polymerase Complex and Facilitating Type I IFN Production.
    J Immunol. 2024 Mar 13:ji2300613. doi: 10.4049/jimmunol.2300613.
    PubMed     Abstract available


  24. READ KA, Amici SA, Farsi S, Cutcliffe M, et al
    PRMT5 Promotes T follicular helper Cell Differentiation and Germinal Center Responses during Influenza Virus Infection.
    J Immunol. 2024 Mar 4:ji2300270. doi: 10.4049/jimmunol.2300270.
    PubMed     Abstract available


  25. AL-AHMAD A
    Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines".
    J Immunol. 2024;212:753.
    PubMed    


  26. MAINO A, Amen A, Plumas J, Bouquet L, et al
    Development of a New Off-the-Shelf Plasmacytoid Dendritic Cell-Based Approach for the Expansion and Characterization of SARS-CoV-2-Specific T Cells.
    J Immunol. 2024;212:825-833.
    PubMed     Abstract available


    February 2024
  27. TANDON P, Abrams ND, Avula LR, Carrick DM, et al
    Unraveling Links between Chronic Inflammation and Long COVID: Workshop Report.
    J Immunol. 2024;212:505-512.
    PubMed     Abstract available


  28. BRADSHAW CM, Georgieva T, Tankersley TN, Taylor-Doyle T, et al
    Cutting Edge: Characterization of Low Copy Number Human Angiotensin-Converting Enzyme 2-Transgenic Mice as an Improved Model of SARS-CoV-2 Infection.
    J Immunol. 2024;212:523-528.
    PubMed     Abstract available


  29. DHANUSHKODI NR, Prakash S, Quadiri A, Zayou L, et al
    Antiviral and Anti-Inflammatory Therapeutic Effect of RAGE-Ig Protein against Multiple SARS-CoV-2 Variants of Concern Demonstrated in K18-hACE2 Mouse and Syrian Golden Hamster Models.
    J Immunol. 2024;212:576-585.
    PubMed     Abstract available


  30. KAMMANN T, Gorin JB, Parrot T, Gao Y, et al
    Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional Anomalies.
    J Immunol. 2024;212:389-396.
    PubMed     Abstract available


    November 2023
  31. LOBBY JL, Danzy S, Holmes KE, Lowen AC, et al
    Both Humoral and Cellular Immunity Limit the Ability of Live Attenuated Influenza Vaccines to Promote T Cell Responses.
    J Immunol. 2023 Nov 20:ji2300343. doi: 10.4049/jimmunol.2300343.
    PubMed     Abstract available


  32. EVANS JP, Liu SL
    Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies.
    J Immunol. 2023;211:1459-1467.
    PubMed     Abstract available


    October 2023
  33. MA W, Loving CL, Driver JP
    From Snoot to Tail: A Brief Review of Influenza Virus Infection and Immunity in Pigs.
    J Immunol. 2023;211:1187-1194.
    PubMed     Abstract available


  34. DIAZ FE, McGill JL
    Modeling Human Respiratory Syncytial Virus (RSV) Infection: Recent Contributions and Future Directions Using the Calf Model of Bovine RSV Disease.
    J Immunol. 2023;211:1180-1186.
    PubMed     Abstract available


  35. NOORUZZAMAN M, Diel DG
    Infection Dynamics, Pathogenesis, and Immunity to SARS-CoV-2 in Naturally Susceptible Animal Species.
    J Immunol. 2023;211:1195-1201.
    PubMed     Abstract available


  36. ROSENBERG-HASSON Y, Holmes TH, Diray-Arce J, Chen J, et al
    Relationship of Heterologous Virus Responses and Outcomes in Hospitalized COVID-19 Patients.
    J Immunol. 2023;211:1224-1231.
    PubMed     Abstract available


    September 2023
  37. LUCKE J, Heinrich F, Malsy J, Meins N, et al
    Intestinal IL-1beta Plays a Role in Protecting against SARS-CoV-2 Infection.
    J Immunol. 2023;211:1052-1061.
    PubMed     Abstract available


    August 2023
  38. SANDBERG JK, Leeansyah E, Eller MA, Shacklett BL, et al
    The Emerging Role of MAIT Cell Responses in Viral Infections.
    J Immunol. 2023;211:511-517.
    PubMed     Abstract available


  39. CAO L, Hui X, Xu T, Mao H, et al
    The RNA-Splicing Ligase RTCB Promotes Influenza A Virus Replication by Suppressing Innate Immunity via Interaction with RNA Helicase DDX1.
    J Immunol. 2023 Aug 9:ji2200799. doi: 10.4049/jimmunol.2200799.
    PubMed     Abstract available


    July 2023
  40. YU H, Worrall LJ, Berger T, Petric M, et al
    Identification of an optimized Receptor-Binding Domain Subunit Vaccine against SARS-CoV-2.
    J Immunol. 2023 Jul 26:ji2300282. doi: 10.4049/jimmunol.2300282.
    PubMed     Abstract available


  41. LAW JC, Watts TH
    Considerations for Choosing T Cell Assays during a Pandemic.
    J Immunol. 2023;211:169-174.
    PubMed     Abstract available


  42. PONDE NO, Shoger KE, Khatun MS, Sarkar MK, et al
    SARS-CoV-2 ORF8 Mediates Signals in Macrophages and Monocytes through MyD88 Independently of the IL-17 Receptor.
    J Immunol. 2023;211:252-260.
    PubMed     Abstract available


    June 2023
  43. CHEUNG MW, Dayam RM, Shapiro JR, Law JC, et al
    Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases.
    J Immunol. 2023 Jun 16:ji2300190. doi: 10.4049/jimmunol.2300190.
    PubMed     Abstract available


  44. MAMBELLI F, Marinho FV, Andrade JM, de Araujo ACVSC, et al
    Recombinant Bacillus Calmette-Guerin Expressing SARS-CoV-2 Chimeric Protein Protects K18-hACE2 Mice against Viral Challenge.
    J Immunol. 2023;210:1925-1937.
    PubMed     Abstract available


  45. PAIDI RK, Jana M, Raha S, Mishra RK, et al
    Prenol, but Not Vitamin C, of Fruit Binds to SARS-CoV-2 Spike S1 to Inhibit Viral Entry: Implications for COVID-19.
    J Immunol. 2023;210:1938-1949.
    PubMed     Abstract available


  46. NAM H, Koh JY, Jung JH, Jeong H, et al
    Distinctive Dynamics and Functions of the CD4+CD25+FOXP3+ Regulatory T Cell Population in Patients with Severe and Mild COVID-19.
    J Immunol. 2023;210:1687-1699.
    PubMed     Abstract available


    May 2023
  47. PHAN JM, Layton ED, Yu KKQ, Aguilar MS, et al
    Cytotoxic T Cells Targeting Spike Glycoprotein Are Associated with Hybrid Immunity to SARS-CoV-2.
    J Immunol. 2023;210:1236-1246.
    PubMed     Abstract available


    March 2023
  48. FINN CM, Dhume K, Prokop E, Strutt TM, et al
    STAT1 Controls the Functionality of Influenza-Primed CD4 T Cells but Therapeutic STAT4 Engagement Maximizes Their Antiviral Impact.
    J Immunol. 2023 Mar 24:ji2200407. doi: 10.4049/jimmunol.2200407.
    PubMed     Abstract available


  49. HEMANN EA, Knoll ML, Wilkins CR, Subra C, et al
    A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity.
    J Immunol. 2023 Mar 20:ji2300026. doi: 10.4049/jimmunol.2300026.
    PubMed     Abstract available


  50. VAN DE WALL S, Crooks S, Varga SM, Badovinac VP, et al
    Cutting Edge: Influenza-Induced CD11alo Airway CD103+ Tissue Resident Memory T Cells Exhibit Compromised IFN-gamma Production after In Vivo TCR Stimulation.
    J Immunol. 2023 Mar 13:ji2200931. doi: 10.4049/jimmunol.2200931.
    PubMed     Abstract available


  51. ZHAO Y, Xiao W, Wu Y, Fan W, et al
    Parallel T Cell Immunogenic Regions in Influenza B and A Viruses with Distinct Nuclear Export Signal Functions: The Balance between Viral Life Cycle and Immune Escape.
    J Immunol. 2023 Mar 10:ji2200243. doi: 10.4049/jimmunol.2200243.
    PubMed     Abstract available


  52. SHAMSELDIN MM, Kenney A, Zani A, Evans JP, et al
    Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology.
    J Immunol. 2023 Mar 6:ji2200297. doi: 10.4049/jimmunol.2200297.
    PubMed     Abstract available


    February 2023
  53. QUINN M, Parra-Rodriguez L, Alsoussi WB, Ayres C, et al
    Persons with HIV Develop Spike-Specific Lymph Node Germinal Center Responses following SARS-CoV-2 Vaccination.
    J Immunol. 2023 Feb 13:ji2200920. doi: 10.4049/jimmunol.2200920.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.